ASEAN Insight Provider, CrossASEAN Research

Angus Mackintosh

ASEAN Insight Provider

CrossASEAN Research

At CrossASEAN Research we strive to produce unbiased and differentiated on the ground insights on companies across South East Asia. Our Research is produced for the most part after face to face meetings and conversations with company management to dig deep into the long term vision and strategy of the companies we cover. We seek to deliver investable and actionable themes on sectors and markets across SE Asia, often in collaboration with other Insight Providers across the region, pooling the vast experience of the analysts within the Smartkarma Ecosystem. We also offer bespoke work and tailor made trips for our clients. 

Insights across South East Asia

Equity Bottom-Up

<section class="figure"><a href="https://www.smartkarma.com/entities/bukalapak" target="_blank" data-smartkarma-citation="entities:33575:1" rel="noopener">Bukalapak (BUKA IJ)</a> released a strong set of 2Q2021 results with +55.7% growth in TPV bringing 1H2021 TPV (Total Processing Value) growth to +54%. It reported a +37% YoY growth in revenue for 2Q2021.</section>
<section class="figure"></section>
<section class="figure"></section>
<section class="figure"></section>
<section class="figure"> The company's Mitra business continued to be the key driver, accounting for 48% of TPV in 2Q2021 versus 22% a year ago, with a growth rate of +292% YoY in 2Q2021.</section>
<section class="figure"></section>
<section class="figure"></section>
<section class="figure">There was some reduction in the take-rate in 2Q2021, which some analysts may focus on but this was explained as due to a change in product mix and temporary. We address concerns regarding the take rate later but they seem overdone.</section>
<section class="figure"></section>
<section class="figure"></section>
<section class="figure">
<section class="figure">
<section class="figure">Mitra Bukalapak continues to be the main growth engine for the company, with 2Q2021 Mitra TPV increasing by +237% YoY, to IDR14.2tn.</section>
<section class="figure"></section>
<section class="figure"></section>
</section>
<p>Mitra Bukalapak’s contribution margin after S&amp;M cost improved from -1.0% of TPV in FY2020 to -0.5% of TPV in Mitra’s operating loss as a ratio to TPV improved from 1.2% in FY20 to 0.6% in 1H2021.</p>
<section class="figure">
<figure class="editor-figure mceNonEditable"></figure>
</section>
</section>
<section class="figure"></section>
<section class="figure"><a href="https://www.smartkarma.com/entities/bukalapak" target="_blank" data-smartkarma-citation="entities:33575:1" rel="noopener">Bukalapak (BUKA IJ)</a> management re-iterated its strategy to continue to help enhance the performance of its Mitra's and sellers on the platform following a more of a Shopify model than one like <a href="https://www.smartkarma.com/entities/amazon-com-inc" target="_blank" data-smartkarma-citation="entities:409:1" rel="noopener">Amazon.com Inc (AMZN US)</a>.</section>
<section class="figure"></section>
<p></p>
<p><a href="https://www.smartkarma.com/entities/bukalapak" target="_blank" data-smartkarma-citation="entities:33575:1" rel="noopener">Bukalapak (BUKA IJ)</a> maintains that around 90% of its Mitra customers use only <a href="https://www.smartkarma.com/entities/bukalapak" target="_blank" data-smartkarma-citation="entities:33575:1" rel="noopener">Bukalapak (BUKA IJ)</a> given that it addresses many uses and allows them to make more money. </p>
<p><a href="https://www.smartkarma.com/entities/tokopedia-pt" target="_blank" data-smartkarma-citation="entities:24239:1" rel="noopener">Tokopedia</a> and Shopee are much more reliant on aggressive capital to expand, which is not an effective long-term strategy for Mitra customers. It is also difficult to discount FMCG products for any length of time given that principles keep a handle on price levels.</p>
<p>Management also revealed that its first collaboration with <a href="https://www.smartkarma.com/entities/grabtaxi-holdings-pte-ltd" target="_blank" data-smartkarma-citation="entities:26950:1" rel="noopener">Grab</a> will focus on GrabMart, providing fresh food products for GrabMart's restaurant customers but more collaboration is expected on an incremental basis going forward. <a href="https://www.smartkarma.com/entities/bukalapak" target="_blank" data-smartkarma-citation="entities:33575:1" rel="noopener"></a></p>
<p><a href="https://www.smartkarma.com/entities/bukalapak" target="_blank" data-smartkarma-citation="entities:33575:1" rel="noopener">Bukalapak (BUKA IJ)</a> management is expecting annual growth in TPV of +50%-75% per annum, with 2022 seen as a potentially even stronger year, with better purchasing power coming through post-pandemic and greater vaccination levels.</p>
<p>The company expects to break even at the EBITDA level by 2023 under current expectations. This accounts for rising revenues, growing take-rates, and lower S&amp;M costs. We continue to take a positive view on the outlook on <a href="https://www.smartkarma.com/entities/bukalapak" target="_blank" data-smartkarma-citation="entities:33575:1" rel="noopener">Bukalapak (BUKA IJ)</a> and do not see the short-term contraction in the take-rate as an issue.  Valuations look quite high relative to peers but the company is much closer to breakeven versus peers and given its predominantly 1P model, revenue is not far off the gross profit. </p>
<div></div>
<div>
<div>
<div class="content-remarks">
<p></p>
</div>
</div>
</div>

Bukalapak (BUKA IJ) released a strong set of 2Q2021 results with +55.7% growth in TPV bringing 1H2021 TPV (Total Processing Value) growth to +54%. It reported a +37% YoY growth in revenue for 2Q2021.



 The company's Mitra business continued to be the key driver, accounting for 48% of TPV in 2Q2021 versus 22% a year ago, with a growth rate of +292% YoY in 2Q2021.


There was some reduction in the take-rate in 2Q2021, which some analysts may focus on but this was explained as due to a change in product mix and temporary. We address concerns regarding the take rate later but they seem overdone.




Mitra Bukalapak continues to be the main growth engine for the company, with 2Q2021 Mitra TPV increasing by +237% YoY, to IDR14.2tn.



Mitra Bukalapak’s contribution margin after S&amp;M cost improved from -1.0% of TPV in FY2020 to -0.5% of TPV in Mitra’s operating loss as a ratio to TPV improved from 1.2% in FY20 to 0.6% in 1H2021.





Bukalapak (BUKA IJ) management re-iterated its strategy to continue to help enhance the performance of its Mitra's and sellers on the platform following a more of a Shopify model than one like Amazon.com Inc (AMZN US).


Bukalapak (BUKA IJ) maintains that around 90% of its Mitra customers use only Bukalapak (BUKA IJ) given that it addresses many uses and allows them to make more money. 
Tokopedia and Shopee are much more reliant on aggressive capital to expand, which is not an effective long-term strategy for Mitra customers. It is also difficult to discount FMCG products for any length of time given that principles keep a handle on price levels.
Management also revealed that its first collaboration with Grab will focus on GrabMart, providing fresh food products for GrabMart's restaurant customers but more collaboration is expected on an incremental basis going forward. 
Bukalapak (BUKA IJ) management is expecting annual growth in TPV of +50%-75% per annum, with 2022 seen as a potentially even stronger year, with better purchasing power coming through post-pandemic and greater vaccination levels.
The company expects to break even at the EBITDA level by 2023 under current expectations. This accounts for rising revenues, growing take-rates, and lower S&amp;M costs. We continue to take a positive view on the outlook on Bukalapak (BUKA IJ) and do not see the short-term contraction in the take-rate as an issue.  Valuations look quite high relative to peers but the company is much closer to breakeven versus peers and given its predominantly 1P model, revenue is not far off the gross profit. 









Overseas Chinese Equities, Aequitas Research

Ming Lu

Overseas Chinese Equities

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

<ul>
<li>The lower growth rate in 2Q21 was due to the high comparison base last year.</li>
<li>The new rule of time limit is not a concern.</li>
<li>The pandemic will pull players back to their mobile phones.</li>
<li>Our concern is expense in minor businesses.</li>
<li>We conclude an upside of 7.6%.</li>
</ul>


The lower growth rate in 2Q21 was due to the high comparison base last year.
The new rule of time limit is not a concern.
The pandemic will pull players back to their mobile phones.
Our concern is expense in minor businesses.
We conclude an upside of 7.6%.


NetEase (NTES): Slower in 2Q21, But Do Not Short It

Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

<p>We have discussed previously that the Chinese central government could impose tightening measure on online game companies to restrict screen time for the youth. Last night the NPPA announced a notice further tightening the youth playing. In this note, we will take a look at the notice and assess the impact on Tencent and Netease. We are of the view that this policy will have little impact on the two companies. </p>

We have discussed previously that the Chinese central government could impose tightening measure on online game companies to restrict screen time for the youth. Last night the NPPA announced a notice further tightening the youth playing. In this note, we will take a look at the notice and assess the impact on Tencent and Netease. We are of the view that this policy will have little impact on the two companies. 

Tencent/Netease: Online Game Tightening Coming to an End

Japan/Asia Long-Short, LightStream Research

Mio Kato

Japan/Asia Long-Short

Long-Short Analysis on Japan, Asia and the World

LightStream Research

LightStream conducts quantitatively rigorous and data-driven analysis with a focus on Japan and Asia.

We consistently cover the Tech, Consumer and Industrial sectors, and provide ECM and Events coverage more broadly.

We supplement traditional qualitative insights from company relationships with a robust quantitative foundation that examines as much historical data as is available.
We further refine the accuracy of our insights and calls through the use of alternative data to flesh out current trends, and through a valuation framework that emphasises non-superficial peer group selection and a proper attempt to understand the metrics and changes that have driven security valuations in the past.

<p>Overnight many Chinese gaming-related names fell ~3% on news that China would be restricting playing time for minors to just three hours a week, specifically 20:00-21:00 on Friday, Saturday and Sunday. The market reaction grossly underestimates how drastic these restrictions will be for gaming companies and seems to simply be superficially looking at the low single-digit revenue contribution percentages of minors.</p>

Overnight many Chinese gaming-related names fell ~3% on news that China would be restricting playing time for minors to just three hours a week, specifically 20:00-21:00 on Friday, Saturday and Sunday. The market reaction grossly underestimates how drastic these restrictions will be for gaming companies and seems to simply be superficially looking at the low single-digit revenue contribution percentages of minors.

China Gaming Restrictions Are FAR More Severe Than the Market Is Assuming

China and US Equity Analyst

Roger Xie

<ul>
<li>The long-awaited China A-share Index future finally received approval from regulators from both Hong Kong and China (<a href="https://www.hkex.com.hk/News/News-Release/2021/210820news?sc_lang=en" target="_blank" rel="noopener">news link</a>). The to-be-launched product is MSCI China A50 Connect Index, which is different from investors' expectation of MSCI China Index future. However, we still believe the move is a game changer for <a href="https://www.smartkarma.com/entities/hong-kong-exchanges-clearing" target="_blank" data-smartkarma-citation="entities:490:1" rel="noopener">HKEX (388 HK)</a> derivative business as investors' increasing exposure in China A-share cash equity market and index future. This will also put a direct competition pressure on <a href="https://www.smartkarma.com/entities/singapore-exchange-ltd" target="_blank" data-smartkarma-citation="entities:1047:1" rel="noopener">SGX (SGX SP)</a> as its popular FTSE A50 Index future accounting around 17% of its total revenue. We believe offshore investors would like to gradually shift their China A-share Index exposure to <a href="https://www.smartkarma.com/entities/hong-kong-exchanges-clearing" target="_blank" data-smartkarma-citation="entities:490:1" rel="noopener">HKEX (388 HK)</a> from <a href="https://www.smartkarma.com/entities/singapore-exchange-ltd" target="_blank" data-smartkarma-citation="entities:1047:1" rel="noopener">SGX (SGX SP)</a> </li>
<li>We estimate that ADV (Average Daily Volume) of MSCI China A50 Connect contract will be ramped up at 1.5-2.0x the volume of FTSE A50 at its launch, given the ADT (Average Daily Turnover) of stock connect northbound (China A-share cash equity market) has reached RMB 120bn. There is increasing demands from offshore investors for hedging and speculation. In a long-run, we believe ADV of MSCI China A50 could be more than 5x of ADV of FTSE A50 as offshore investors' exposure on China A-share cash equity grows. We expect the derivative business contribution to revenue at HKEx will likely grow to 25% from current 16%, which will reshape HKEx with more balanced revenue stream from both cash equity and derivative. </li>
<li>For 1H2021, <a href="https://www.smartkarma.com/entities/hong-kong-exchanges-clearing" target="_blank" data-smartkarma-citation="entities:490:1" rel="noopener">HKEX (388 HK)</a> delivered a broadly in-line results. It reported 2Q2021 profits of HK$2.77bn, down 7% year-over-year. Cash equity ADT was quite strong and up 31% year-over-year, but down 34% from 1Q 2021. But the derivatives business did not have the same volume pick-up with HK derivatives ADV -5% year-over-year and LME ADV -2% year-over-year. We are the believer that HKEx will play a key role on offshore China listings. Ongoing regulatory uncertainty is likely to accelerate the Chinese ADS' to diversify their listing risk and to benefit HKEx as a preferred offshore listing venue.  We forecast <a href="https://www.smartkarma.com/entities/hong-kong-exchanges-clearing" target="_blank" data-smartkarma-citation="entities:490:1" rel="noopener">HKEX (388 HK)</a> Securities ADT of HK$240bn in FY 21 (excluding Stock Connect Northbound volume)  and remain bullish on <a href="https://www.smartkarma.com/entities/hong-kong-exchanges-clearing" target="_blank" data-smartkarma-citation="entities:490:1" rel="noopener">HKEX (388 HK)</a>  and have TP HKD 550. </li>
</ul>


The long-awaited China A-share Index future finally received approval from regulators from both Hong Kong and China (news link). The to-be-launched product is MSCI China A50 Connect Index, which is different from investors' expectation of MSCI China Index future. However, we still believe the move is a game changer for HKEX (388 HK) derivative business as investors' increasing exposure in China A-share cash equity market and index future. This will also put a direct competition pressure on SGX (SGX SP) as its popular FTSE A50 Index future accounting around 17% of its total revenue. We believe offshore investors would like to gradually shift their China A-share Index exposure to HKEX (388 HK) from SGX (SGX SP) 
We estimate that ADV (Average Daily Volume) of MSCI China A50 Connect contract will be ramped up at 1.5-2.0x the volume of FTSE A50 at its launch, given the ADT (Average Daily Turnover) of stock connect northbound (China A-share cash equity market) has reached RMB 120bn. There is increasing demands from offshore investors for hedging and speculation. In a long-run, we believe ADV of MSCI China A50 could be more than 5x of ADV of FTSE A50 as offshore investors' exposure on China A-share cash equity grows. We expect the derivative business contribution to revenue at HKEx will likely grow to 25% from current 16%, which will reshape HKEx with more balanced revenue stream from both cash equity and derivative. 
For 1H2021, HKEX (388 HK) delivered a broadly in-line results. It reported 2Q2021 profits of HK$2.77bn, down 7% year-over-year. Cash equity ADT was quite strong and up 31% year-over-year, but down 34% from 1Q 2021. But the derivatives business did not have the same volume pick-up with HK derivatives ADV -5% year-over-year and LME ADV -2% year-over-year. We are the believer that HKEx will play a key role on offshore China listings. Ongoing regulatory uncertainty is likely to accelerate the Chinese ADS' to diversify their listing risk and to benefit HKEx as a preferred offshore listing venue.  We forecast HKEX (388 HK) Securities ADT of HK$240bn in FY 21 (excluding Stock Connect Northbound volume)  and remain bullish on HKEX (388 HK)  and have TP HKD 550. 


HKEx (388.HK): A-Share Index Future Launch, A Game Changer for HKEx Derivative Business

China

NetEase, Inc. operates as an leading internet technology company providing online services including content, community, communication, and commerce. The Company develops and operates online games, electronic commerce, internet media, innovative business, and other businesses. NetEase expands its businesses to Japan, North American, and other other international markets.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

NetEase (9999 HK)

Bukalapak (BUKA IJ) - The Magic of Mitra

Bukalapak released an impressive set of 2Q2021 results, with the MSME Mitra business now close to half its TPV and showing triple-digit YoY growth....

Angus Mackintosh

NetEase (NTES): Slower in 2Q21, But Do Not Short It

The lower growth rate in 2Q21 was due to the high comparison base last year. The new rule of time limit is not a concern. The pandemic will pull...

Ming Lu

Tencent/Netease: Online Game Tightening Coming to an End

Last night the NPPA announced a notice further tightening the youth playing. In this note, we will take a look at the notice and continue to...

Ke Yan, CFA, FRM

China Gaming Restrictions Are FAR More Severe Than the Market Is Assuming

We believe the market reaction to China's new gaming restrictions grossly underestimates how drastic the long-term impact will be.

Mio Kato

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Bukalapak (BUKA IJ) - The Magic of Mitra

Bukalapak released an impressive set of 2Q2021 results, with the MSME Mitra business now close to half its TPV and showing triple-digit YoY growth....

Angus Mackintosh

NetEase (NTES): Slower in 2Q21, But Do Not Short It

The lower growth rate in 2Q21 was due to the high comparison base last year. The new rule of time limit is not a concern. The pandemic will pull...

Ming Lu

Tencent/Netease: Online Game Tightening Coming to an End

Last night the NPPA announced a notice further tightening the youth playing. In this note, we will take a look at the notice and continue to...

Ke Yan, CFA, FRM

China Gaming Restrictions Are FAR More Severe Than the Market Is Assuming

We believe the market reaction to China's new gaming restrictions grossly underestimates how drastic the long-term impact will be.

Mio Kato

HKEx (388.HK): A-Share Index Future Launch, A Game Changer for HKEx Derivative Business

We expect China A-share index future will reshape HKEx with more balanced revenue stream from both cash equity and derivative. We remain bullish on...

Roger Xie